NCT05160402View on ClinicalTrials.gov

Evaluation of IGM-6268 in Healthy Volunteers

PHASE1TerminatedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 7, 2021

Primary Completion Date

June 15, 2022

Study Completion Date

August 18, 2022

Conditions
Healthy Volunteers
Interventions
DRUG

IGM-6268

Active comparator

DRUG

Placebo

Placebo comparator

Trial Locations (1)

43213

Aventiv Research, Columbus

Sponsors
All Listed Sponsors
lead

IGM Biosciences, Inc.

INDUSTRY

NCT05160402 - Evaluation of IGM-6268 in Healthy Volunteers | Biotech Hunter | Biotech Hunter